T. Kurita, Tomomi Kitaichi, Takako Nagao
Mar 3, 2014
Citations
1
Influential Citations
16
Citations
Journal
Pharmacoepidemiology and Drug Safety
Abstract
To obtain safety and effectiveness data on a combined anti‐HIV drug, Epzicom (abacavir 600 mg/lamivudine 300 mg), a post‐marketing surveillance on Epzicom that was required by the Japanese regulatory authority was conducted between January 2005 and December 2010.